DT Cochrane The U.S. Supreme Court has ruled that pieces of the human gene cannot be patented. The ruling invalidated two high profile cancer detection patents awarded to Myriad Genetics (MYGN). The ruling upheld the patenting of synthetic DNA. This partial decapitalization of the human genome showed up as decumulation by the company. Compared to […]
Continue Reading